MIMG 170Cell and Gene Therapy
Microbiology, Immunology, and Molecular Genetics · 4 units · Undergraduate upper division (100-199)
State-of-art study of stem cells and gene therapy, and approaches to treat congenital/genetic defects, diseases, or injuries in humans. Review of current knowledge of human stem cells and viral and non-viral gene delivery strategies, and how they can be safely evaluated in animal models of disease. Introduction to ethical and legal issues related to cell and gene therapy as well as how to translate therapies into practice including aspects of cell and gene therapy intellectual property, regulatory, and Food and Drug Administration considerations. Includes innovative mock company team pitches to venture capitalists to learn how to raise capital for their new inventions based on what they have learned.
Letter grading.
When it runs
- Spring 2026
- Spring 2027
Scheduled, not typical — from UCLA’s Schedule of Classes, which publishes Fall 2025 through Spring 2027 and nothing before it.
Requisites
Official UCLA wording
Requisites: Chemistry 153A, Life Sciences 107.
BruinTree reads · Prerequisite
confidence 1.00 · from textRequires
Everything that has to come before this course, not just the courses named in the requisite above.
MIMG 170
- CHEM 153ABiochemistry: Introduction to Structure, Enzymes, and Metabolism
- LIFESCI 107Genetics
- CHEM 14AGeneral Chemistry for Life Scientists I
- LIFESCI 30AMathematics for Life Scientists
- LIFESCI 7CPhysiology and Human Biology
- CHEM 14CStructure of Organic Molecules
- CHEM 20AChemical Structure
- CHEM 30AOrganic Chemistry I: Structure and Reactivity
2 direct requisites. Showing 18 courses over 3 levels; the branches marked with a count carry on past it. Every course here opens its own tree.
Unlocks
What this course is a requisite for, and what those courses lead to in turn.
No course in the catalog lists this as a requisite.